Statens Serum Institut

Patent Owner

Follow Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 27225
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 6180
 
 
 
C07K PEPTIDES 4125
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 3118
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 299
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 293
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 154
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1156

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2016/0228,528 A SINGLE OR MULTISTAGE MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS SUBUNIT VACCINEJan 28, 14Aug 11, 16[A61K, C07K]
2015/0290,311 M. TUBERCULOSIS VACCINESOct 18, 13Oct 15, 15[A61K, C07K]
2015/0093,407 TUBERCULOSIS TB VACCINE TO PREVENT REACTIVATIONDec 12, 14Apr 02, 15[A61K]
2014/0275,478 Vaccines against Chlamydia sp.Mar 17, 14Sep 18, 14[A61K]
2014/0154,696 PCR DIAGNOSTICS OF DERMATOPHYTES AND OTHER PATHOGENIC FUNGIFeb 07, 14Jun 05, 14[C12N, C12Q]
2014/0112,979 METHODS FOR PRODUCING LIPOSOMESJul 03, 12Apr 24, 14[A61K]
2011/0229,518 OPTIMIZED INFLUENZA VACCINESNov 27, 09Sep 22, 11[C07H, A61P, A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9,410,960 Method of diagnosing galactosemia in neonatal screeningNov 28, 13Aug 09, 16[C12Q, G01N]
9,279,160 Jun 17, 10Mar 08, 16[C12P, C12Q]
9,140,691 Diagnostic blood test using adsorption on filter paperNov 30, 07Sep 22, 15[G01N]
9,074,001 Tuberculosis TB vaccine to prevent reactivationApr 23, 10Jul 07, 15[A61K, C07K]
8,889,142 antigens for vaccine and diagnostic useOct 11, 05Nov 18, 14[A61K, C07K]
8,703,151 Tuberculosis vaccines comprising antigens expressed during the latent infection phaseSep 20, 12Apr 22, 14[C07H, A61K]
8,563,009 Use of monomycolyl glycerol (MMG) as an adjuvantJun 26, 08Oct 22, 13[A61K]
8,557,258 Vaccines comprising TB10.4Aug 30, 11Oct 15, 13[A61K]
8,293,250 Tuberculosis vaccines comprising antigens expressed during the latent infection phaseDec 22, 11Oct 23, 12[C07H, A61K]
8,288,090 Influenza vaccinesJan 19, 10Oct 16, 12[C12Q]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0205,656 MODIFIED CATIONIC LIPOSOME ADJUVANTSABANJan 23, 14Jul 24, 14[A61K]
2013/0149,324 THERAPEUTIC TB VACCINEABANFeb 09, 12Jun 13, 13[C07K]
2012/0156,282 EXPANDING THE T CELL REPERTOIRE TO INCLUDE SUBDOMINANT EPITOPES BY VACCINATION WITH ANTIGENS DELIVERED AS PROTEIN FRAGMENTS OR PEPTIDE COCKTAILSABANDec 16, 11Jun 21, 12[C12P, A61P, A61K]
8,142,797 Therapeutic TB vaccineExpiredMay 21, 10Mar 27, 12[A61K]
8,105,614 Expanding the T cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktailsExpiredJun 27, 07Jan 31, 12[A01N, A61K]
2011/0287,087 MODIFIED CATIONIC LIPOSOME ADJUVANSABANNov 10, 09Nov 24, 11[A61P, A61K]
2011/0020,387 MALARIA VACCINEABANJun 03, 10Jan 27, 11[C12N, C12P, A61P, A61K, C07K]
2010/0311,041 PCR DIAGNOSTICS OF DERMATOPHYTES AND OTHER PATHOGENIC FUNGIABANJun 13, 06Dec 09, 10[C07H, C12Q]
2010/0015,171 VACCINES COMPRISING TB 10.4ABANJul 10, 09Jan 21, 10[A61P, A61K, C07K]
2008/0299,151 Influenza vaccinesABANMay 30, 08Dec 04, 08[A61P, A61K]
2007/0184,073 TB diagnostic based on antigens from M. tuberculosisABANAug 02, 05Aug 09, 07[C12N, C07H, C12Q, A61K, C07K]
2006/0194,206 Diagnostics of diarrheagenic escherichia coli (dec) and shigella sppABANJul 09, 04Aug 31, 06[C12Q]
6,982,085 TB diagnostic based on antigens from M. tuberculosisExpiredMay 02, 02Jan 03, 06[C12N, A61K]
6,921,808 Purification process for large scale production of Gc-globulin, the Gc-globulin produced hereby, a use of Gc-globulin and a Gc-globulin medicinal productExpiredAug 18, 04Jul 26, 05[C07K]
6,806,355 Purification process for large scale production of Gc-globulin, the Gc-globulin produced hereby, a use of Gc.globulin and a Gc-globulin medicinal productExpiredAug 13, 02Oct 19, 04[C07K]
2004/0086,949 Method for preparing a ligand presenting assembly (LPA), an LPA and uses thereofABANDec 01, 03May 06, 04[G01N, C07K]
2004/0072,162 Hiv peptides and nucleic acids encoding them for diagnosis and control of hiv infectionABANApr 10, 03Apr 15, 04[C12Q, G06F, G01N]
2004/0057,963 Therapeutic TB vaccineABANJul 11, 03Mar 25, 04[A61K]
2004/0018,574 Molecular differences between species of the M. tuberculosis complexABANMar 14, 03Jan 29, 04[A61K, G01N, C07K]
2004/0013,685 Nucleic acid fragments and polypeptide fragments derived from M. tuberculosisABANJun 01, 01Jan 22, 04[C12N, C07H, C12P, A61K, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.